Physician profile
Chad Victor Ruffin
NPI 1861629636
$2,779.89
in general payments reported to CMS, 2019-2025
11 companies · $1,495 in 2025
The $1,495 reported for 2025 was more than what 86% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $358 · 2020: $203 · 2021: $132 · 2022: $154 · 2023: $185 · 2024: $253 · 2025: $1,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,368 · Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,368.00 |
| Food and Beverage | $564.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $1,458.49 | 2025 | |
| Cochlear Americas | $845.82 | 2019-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Medtronic, INC. | $168.76 | 2023 | Nim Vital, Nim-Response |
| Grace Medical, INC. | $94.32 | 2024 | |
| Advanced Bionics, LLC | $71.68 | 2019-2021 | |
| Acclarent, INC | $35.89 | 2019 | |
| Kaleo, INC. | $34.64 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $21.79 | 2019 | |
| Alk-Abello, INC | $20.13 | 2019 | |
| Integra Lifesciences Corporation | $16.20 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Stryker Corporation | $12.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Ruffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.